1	Leaders	leader	NNS	_	13	nsubj	13:A0=PAG
2	from	from	IN	_	1	prep	_
3	academic	academic	JJ	_	4	amod	_
4	institutions	institution	NNS	_	2	pobj	_
5	,	,	,	_	4	punct	_
6	non-profit	non-profit	JJ	_	7	amod	_
7	organizations	organization	NNS	_	4	conj	_
8	,	,	,	_	7	punct	_
9	and	and	CC	_	7	cc	_
10	pharmaceutical	pharmaceutical	JJ	p2=NN	11	amod	_
11	companies	company	NNS	_	7	conj	_
12	will	will	MD	_	13	aux	13:AM-MOD
13	meet	meet	VB	pb=meet.03	0	root	_
14	in	in	IN	_	13	prep	13:AM-LOC
15	Cambridge	cambridge	NNP	_	14	pobj	_
16	,	,	,	_	15	punct	_
17	Mass	mass	NNP	_	15	appos	_
18	.	.	.	_	13	punct	_

1	,	,	,	_	9	punct	_
2	on	on	IN	_	9	prep	9:AM-TMP
3	Monday	monday	NNP	_	2	pobj	_
4	,	,	,	_	3	punct	_
5	May	may	NNP	_	3	appos	_
6	19	0	CD	_	5	num	_
7	,	,	,	_	9	punct	_
8	to	to	TO	_	9	aux	_
9	discuss	discuss	VB	pb=discuss.01	0	root	_
10	biomarkers	biomarker	NNS	_	9	dobj	9:A1=PPT
11	in	in	IN	p2=RP	10	prep	_
12	amyotrophic	amyotrophic	JJ	p2=NN	14	amod	_
13	lateral	lateral	JJ	p2=NN	14	amod	_
14	sclerosis	sclerosis	NN	_	11	pobj	_
15	(	(	-LRB-	_	14	punct	_
16	ALS	als	NNP	p2=RB	14	appos	_
17	)	)	-RRB-	_	14	punct	_
18	.	.	.	_	9	punct	_

1	A	a	DT	_	2	det	_
2	biomarker	biomarker	NN	_	3	nsubj	3:A1=PPT
3	is	be	VBZ	pb=be.01	0	root	_
4	any	any	DT	_	5	det	_
5	measurement	measurement	NN	_	3	attr	17:A0=PAG;3:A2=PRD
6	,	,	,	_	5	punct	_
7	such	such	JJ	_	8	amod	_
8	as	as	IN	_	5	prep	_
9	a	a	DT	_	11	det	_
10	blood	blood	NN	_	11	nn	_
11	test	test	NN	_	8	pobj	_
12	or	or	CC	_	11	cc	_
13	imaging	imaging	NN	p2=VBG	14	nn	_
14	result	result	NN	p2=VB	11	conj	_
15	,	,	,	_	5	punct	_
16	that	that	WDT	p2=IN	17	nsubj	17:R-A0
17	tracks	track	VBZ	pb=track.01	5	rcmod	_
18	the	the	DT	_	20	det	_
19	disease	disease	NN	_	20	nn	_
20	process	process	NN	_	17	dobj	17:A1=PPT
21	and	and	CC	_	17	cc	_
22	the	the	DT	_	23	det	_
23	effects	effect	NNS	_	17	conj	_
24	of	of	IN	_	23	prep	_
25	treatment	treatment	NN	_	24	pobj	_
26	.	.	.	_	3	punct	_

1	Cholesterol	cholesterol	NNP	p2=NN	2	nsubj	2:A1=PPT
2	is	be	VBZ	pb=be.01	0	root	_
3	a	a	DT	_	4	det	_
4	biomarker	biomarker	NN	_	2	attr	2:A2=PRD
5	for	for	IN	_	4	prep	_
6	heart	heart	NN	_	7	nn	_
7	disease	disease	NN	_	5	pobj	_
8	,	,	,	_	7	punct	_
9	for	for	IN	_	15	prep	_
10	instance	instance	NN	_	9	pobj	_
11	,	,	,	_	2	punct	_
12	because	because	IN	_	15	mark	_
13	its	its	PRP$	_	14	poss	_
14	level	level	NN	_	15	nsubj	15:A1=PPT
15	correlates	correlate	VBZ	p2=NNS|pb=correlate.01	2	advcl	_
16	with	with	IN	_	15	prep	15:A2=PPT
17	the	the	DT	_	18	det	_
18	risk	risk	NN	_	16	pobj	_
19	for	for	IN	_	18	prep	_
20	the	the	DT	_	21	det	_
21	disease	disease	NN	_	19	pobj	_
22	.	.	.	_	2	punct	_

1	Biomarkers	biomarker	NNS	_	2	nsubj	2:A1=PPT
2	are	be	VBP	pb=be.01	0	root	_
3	especially	especially	RB	_	4	advmod	_
4	important	important	JJ	_	2	acomp	2:A2=PRD
5	for	for	IN	_	4	prep	_
6	therapy	therapy	NN	_	7	nn	_
7	development	development	NN	_	5	pobj	_
8	because	because	IN	_	10	mark	_
9	they	they	PRP	_	10	nsubj	10:A0=PAG
10	allow	allow	VBP	pb=allow.01	2	advcl	2:AM-CAU
11	researchers	researcher	NNS	_	13	nsubj	13:A0=PAG
12	to	to	TO	_	13	aux	_
13	determine	determine	VB	pb=determine.01	10	ccomp	10:A1=PPT
14	if	if	IN	_	19	complm	_
15	a	a	DT	_	17	det	_
16	new	new	JJ	_	17	amod	_
17	treatment	treatment	NN	_	19	nsubj	19:A0=PAG
18	is	be	VBZ	_	19	aux	_
19	having	have	VBG	pb=have.03	13	ccomp	13:A1=PPT
20	the	the	DT	_	23	det	_
21	intended	intend	VBN	p2=JJ|pb=intend.01	23	amod	_
22	biological	biological	JJ	_	23	amod	_
23	effect	effect	NN	_	19	dobj	19:A1=PPT;21:A1=PPT
24	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	existence	existence	NN	_	9	nsubj	9:A0=PAG
3	of	of	IN	_	2	prep	_
4	a	a	DT	_	7	det	_
5	reliable	reliable	JJ	_	7	amod	_
6	progression	progression	NN	_	7	nn	_
7	biomarker	biomarker	NN	p2=PRP	3	pobj	_
8	can	can	MD	_	9	aux	9:AM-MOD
9	influence	influence	VB	pb=influence.01	0	root	_
10	a	a	DT	_	12	det	_
11	pharmaceutical	pharmaceutical	JJ	p2=NN	12	amod	_
12	company	company	NN	_	14	poss	_
13	's	's	POS	_	12	possessive	_
14	decision	decision	NN	_	9	dobj	9:A1=PPT
15	whether	whether	IN	p2=CC	17	complm	_
16	to	to	TO	_	17	aux	_
17	invest	invest	VB	pb=invest.01	14	ccomp	_
18	the	the	DT	_	19	det	_
19	millions	#crd#	NNS	_	17	dobj	17:A1=PPT
20	of	of	IN	_	19	prep	_
21	dollars	dollar	NNS	_	20	pobj	22:A1=PPT
22	needed	need	VBN	pb=need.01	21	partmod	_
23	to	to	TO	_	24	aux	_
24	support	support	VB	pb=support.01	22	advcl	22:AM-PRP
25	a	a	DT	_	28	det	_
26	large	large	JJ	_	28	amod	_
27	clinical	clinical	JJ	_	28	amod	_
28	trial	trial	NN	_	24	dobj	24:A1
29	.	.	.	_	9	punct	_

1	Most	most	RBS	_	2	advmod	_
2	importantly	importantly	RB	_	6	advmod	6:AM-DIS
3	,	,	,	_	6	punct	_
4	biomarkers	biomarker	NNS	_	6	nsubj	6:A0=PAG;10:A0=PAG
5	would	would	MD	_	6	aux	6:AM-MOD;10:AM-MOD
6	expedite	expedite	VB	pb=expedite.01	0	root	_
7	clinical	clinical	JJ	_	8	amod	_
8	trials	trial	NNS	_	6	dobj	6:A1=PPT
9	and	and	CC	_	6	cc	_
10	determine	determine	VB	p2=VBP|pb=determine.01	6	conj	_
11	whether	whether	IN	_	15	complm	_
12	a	a	DT	_	14	det	_
13	treatment	treatment	NN	_	14	nn	_
14	effect	effect	NN	_	15	nsubj	15:A1=PPT
15	is	be	VBZ	pb=be.01	10	ccomp	10:A1=PPT
16	beneficial	beneficial	JJ	_	15	acomp	15:A2=PRD
17	or	or	CC	_	16	cc	_
18	not	not	RB	_	16	conj	_
19	and	and	CC	_	15	cc	_
20	whether	whether	IN	_	24	mark	_
21	the	the	DT	_	22	det	_
22	drug	drug	NN	_	24	nsubj	24:A0=PAG
23	has	have	VBZ	_	24	aux	_
24	reached	reach	VBN	pb=reach.01	15	conj	_
25	its	its	PRP$	_	26	poss	_
26	target	target	NN	_	24	dobj	24:A1=GOL
27	.	.	.	_	6	punct	_

1	Although	although	IN	_	5	mark	_
2	several	several	JJ	_	3	amod	_
3	biomarkers	biomarker	NNS	_	5	nsubj	5:A0=PPT;7:A0=PAG
4	are	be	VBP	_	5	aux	_
5	emerging	emerge	VBG	pb=emerge.01	14	advcl	14:AM-ADV
6	as	as	IN	_	5	prep	5:A1
7	promising	promise	VBG	p2=JJ|pb=promise.01	6	pcomp	_
8	for	for	IN	_	7	prep	7:A1=GOL
9	ALS	als	NNP	p2=NNS	8	pobj	_
10	,	,	,	_	14	punct	_
11	significant	significant	JJ	_	12	amod	_
12	effort	effort	NN	_	14	nsubjpass	14:A1=PPT
13	is	be	VBZ	_	14	auxpass	_
14	required	require	VBN	pb=require.01	0	root	_
15	to	to	TO	p2=IN	16	aux	_
16	validate	validate	VB	pb=validate.01	14	xcomp	14:AM-PNC
17	and	and	CC	_	16	cc	_
18	standardize	standardize	VB	pb=standardize.01	16	conj	_
19	biomarkers	biomarker	NNS	_	18	dobj	18:A1=PPT
20	.	.	.	_	14	punct	_

1	A	a	DT	_	3	det	_
2	consortium	consortium	NN	_	3	nn	_
3	effort	effort	NN	_	8	nsubj	8:A1=PPT;11:A1=PPT
4	to	to	TO	_	5	aux	_
5	make	make	VB	pb=make.02	3	infmod	_
6	this	this	DT	_	7	nsubj	7:A1=PPT
7	happen	happen	VB	p2=NN|pb=happen.01	5	ccomp	5:A1=PRD
8	is	be	VBZ	pb=be.01	0	root	_
9	essential	essential	JJ	_	8	acomp	8:A2=PRD
10	and	and	CC	_	8	cc	_
11	is	be	VBZ	pb=be.01	8	conj	_
12	the	the	DT	_	13	det	_
13	focus	focus	NN	_	11	attr	11:A2=PRD
14	of	of	IN	_	13	prep	_
15	the	the	DT	_	17	det	_
16	upcoming	upcoming	JJ	_	17	amod	_
17	meeting	meeting	NN	_	14	pobj	_
18	.	.	.	_	8	punct	_

1	This	this	DT	_	2	det	_
2	meeting	meeting	NN	_	5	nsubjpass	5:A1=PPT
3	will	will	MD	_	5	aux	5:AM-MOD
4	be	be	VB	_	5	auxpass	_
5	held	hold	VBN	pb=hold.04	0	root	_
6	in	in	IN	_	5	prep	5:AM-LOC
7	collaboration	collaboration	NN	_	6	pobj	_
8	with	with	IN	_	7	prep	_
9	ALS	als	NNP	_	12	nn	_
10	Therapy	therapy	NNP	_	12	nn	_
11	Development	development	NNP	_	12	nn	_
12	Institute	institute	NNP	_	8	pobj	_
13	(	(	-LRB-	_	12	punct	_
14	ALS	als	NNP	_	15	nn	_
15	TDI	tdi	NNP	_	12	appos	_
16	)	)	-RRB-	_	12	punct	_
17	,	,	,	_	5	punct	_
18	and	and	CC	_	5	cc	_
19	leaders	leader	NNS	_	27	nsubj	27:A0=PAG
20	from	from	IN	_	19	prep	_
21	24	0	CD	_	22	num	_
22	companies	company	NNS	_	20	pobj	_
23	and	and	CC	_	22	cc	_
24	academic	academic	JJ	_	25	amod	_
25	institutions	institution	NNS	_	22	conj	_
26	will	will	MD	_	27	aux	27:AM-MOD
27	attend	attend	VB	pb=attend.01	5	conj	_
28	this	this	DT	_	29	det	_
29	event	event	NN	_	27	dobj	27:A1=PPT
30	.	.	.	_	27	punct	_

1	Other	other	JJ	_	2	amod	_
2	participants	participant	NNS	_	3	nsubj	3:A2=GOL
3	include	include	VBP	pb=include.01	0	root	_
4	Genentech	genentech	NNP	_	3	dobj	3:A1=PPT
5	,	,	,	_	4	punct	_
6	Pfizer	pfizer	NNP	_	4	conj	_
7	,	,	,	_	6	punct	_
8	Astra	astra	NNP	_	9	nn	_
9	Zeneca	zeneca	NNP	_	6	conj	_
10	,	,	,	_	9	punct	_
11	Biogen	biogen	NNP	_	12	nn	_
12	Idec	idec	NNP	_	9	conj	_
13	,	,	,	_	12	punct	_
14	Bristol	bristol	NNP	_	16	hmod	_
15	-	-	HYPH	_	16	hyph	_
16	Myers	myers	NNP	_	17	nn	_
17	Squibb	squibb	NNP	_	12	conj	_
18	,	,	,	_	17	punct	_
19	NextGen	nextgen	NNP	_	20	nn	_
20	Sciences	science	NNPS	_	17	conj	_
21	,	,	,	_	20	punct	_
22	University	university	NNP	_	26	nn	_
23	of	of	IN	_	22	prep	_
24	Massachusetts	massachusetts	NNP	_	23	pobj	_
25	Medical	medical	NNP	_	26	nn	_
26	School	school	NNP	_	20	conj	_
27	,	,	,	_	26	punct	_
28	Massachusetts	massachusetts	NNP	_	30	nn	_
29	General	general	NNP	_	30	nn	_
30	Hospital	hospital	NNP	_	26	conj	_
31	,	,	,	_	30	punct	_
32	SUNY	suny	NNP	_	35	nn	_
33	Upstate	upstate	NNP	_	35	nn	_
34	Medical	medical	NNP	_	35	nn	_
35	University	university	NNP	_	30	conj	_
36	,	,	,	_	35	punct	_
37	Barrow	barrow	NNP	_	39	nn	_
38	Neurological	neurological	NNP	_	39	nn	_
39	Institute	institute	NNP	_	35	conj	_
40	,	,	,	_	39	punct	_
41	Voyager	voyager	NNP	_	42	nn	_
42	Therapeutics	therapeutics	NNP	p2=NNPS	39	conj	_
43	,	,	,	_	42	punct	_
44	Michael	michael	NNP	_	47	nn	_
45	J.	j.	NNP	_	47	nn	_
46	Fox	fox	NNP	_	47	nn	_
47	Foundation	foundation	NNP	_	42	conj	_
48	and	and	CC	_	47	cc	_
49	Brigham	brigham	NNP	_	47	conj	_
50	and	and	CC	_	47	cc	_
51	Women	women	NNP	p2=NNPS	53	poss	_
52	's	's	POS	_	51	possessive	_
53	Hospital	hospital	NNP	p2=NN	47	conj	_
54	,	,	,	_	53	punct	_
55	Harvard	harvard	NNP	_	57	nn	_
56	Medical	medical	NNP	_	57	nn	_
57	School	school	NNP	_	53	conj	_
58	.	.	.	_	3	punct	_

1	"	"	``	_	3	punct	_
2	This	this	DT	_	3	nsubj	3:A1=PPT;14:A1=PPT
3	is	be	VBZ	pb=be.01	22	ccomp	22:A1=PPT
4	an	an	DT	_	7	det	_
5	extremely	extremely	RB	_	6	advmod	_
6	important	important	JJ	_	7	amod	_
7	initiative	initiative	NN	_	3	attr	3:A2=PRD
8	and	and	CC	_	7	cc	_
9	collaboration	collaboration	NN	_	7	conj	_
10	between	between	IN	_	9	prep	_
11	academia	academia	NN	_	10	pobj	_
12	and	and	CC	_	11	cc	_
13	industry	industry	NN	_	11	conj	_
14	is	be	VBZ	pb=be.01	3	conj	_
15	critical	critical	JJ	_	14	acomp	14:A2=PRD
16	to	to	IN	_	15	prep	_
17	the	the	DT	_	18	det	_
18	development	development	NN	_	16	pobj	_
19	of	of	IN	_	18	prep	_
20	biomarkers	biomarker	NNS	_	19	pobj	_
21	,	,	,	_	22	punct	_
22	said	say	VBD	pb=say.01	0	root	_
23	Lucie	lucie	NNP	_	24	nn	_
24	Bruijn	bruijn	NNP	_	22	nsubj	22:A0
25	,	,	,	_	24	punct	_
26	Ph.D.	ph.d.	NNP	p2=NN	24	conj	_
27	,	,	,	_	26	punct	_
28	M.B.A.	m.b.a.	NNP	_	26	conj	_
29	,	,	,	_	28	punct	_
30	The	the	DT	p2=NNP	32	det	_
31	ALS	als	NNP	_	32	nn	_
32	Association	association	NNP	_	35	poss	_
33	's	's	POS	_	32	possessive	_
34	Chief	chief	NNP	_	35	nn	_
35	Scientist	scientist	NNP	_	28	conj	_
36	.	.	.	_	22	punct	_
37	"	"	''	_	22	punct	_

1	I	I	PRP	_	2	nsubj	2:A0=PAG
2	look	look	VBP	pb=look.03	0	root	_
3	forward	forward	RB	_	2	advmod	2:C-V
4	to	to	IN	_	2	prep	2:A1=PPT
5	productive	productive	JJ	_	6	amod	_
6	discussions	discussion	NNS	_	4	pobj	_
7	and	and	CC	_	6	cc	_
8	fruitful	fruitful	JJ	_	9	amod	_
9	partnerships	partnership	NNS	_	6	conj	_
10	in	in	IN	_	6	prep	_
11	the	the	DT	_	12	det	_
12	months	month	NNS	_	10	pobj	_
13	ahead	ahead	RB	_	12	advmod	_
14	.	.	.	_	2	punct	_

1	"	"	``	p2=''	0	root	_

